Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pre vs. Postoperative Adductor Canal Block for TKA
NCT05974501Phase 4Completed
- Sponsor
- University of Miami
- Start
- Sep 2023
- Primary completion
- Jan 2024
- Modality
- Targeted Liposomes, Stealth (PEGylated) Liposomes, Conventional Liposomes
- Countries
- 1
01
Overview
A Phase 4 trial of ropivacaine hydrochloride liposomal suspension injection in postoperative pain, sponsored by University of Miami. Started Sep 2023; status: completed.
02
Drugs
ropivacaine hydrochloride liposomal suspension injection
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT05974501.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05974501.